BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN
BEGIN:VTIMEZONE
TZID:W. Europe Standard Time
BEGIN:STANDARD
DTSTART:20251002T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=3;BYMINUTE=0;BYMONTH=10
TZNAME:W. Europe Standard Time
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:W. Europe Daylight Time
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION: The theme for the PSI Conference 2019 was&ldquo\;Data Driven D
 ecision Making in Medical Research&rdquo\;.&nbsp\; The 2019 PSI Conference
  took place at the Queen Elizabeth II Centre (QEII)\, London\, from&nbsp\;
 2nd&nbsp\;to 5th June 2019.\nThe conference consisted of a variety of plen
 ary and parallel sessions\, as well as breakout discussion sessions\, work
 shops\, a poster session and the Annual General Meeting. The conference ra
 n over three full days from Monday to Wednesday\, with an optional half da
 y training course on the&nbsp\; Sunday afternoon.&nbsp\;\nSessions include
 d early phase innovative trial design\, industry best practice - 10 years 
 on\, statistical issues in safety drug labelling\, model based dose findin
 g designs\, an update from Transcelerate and much more\, with speakers fro
 m industry\, academia and regulatory agencies.\n\nWe welcomed abstracts on
  any subject but were interested in the following topics\; decision making
 \, bayesian topics within early or late phase\, causal inference\, future 
 trends\, pre-clinical statistics\, patient reported outcomes\, and patient
 -centric data. \nKate Taylor\nPSI Conference Chair\n
DTEND:20190605T123000Z
DTSTAMP:20260418T202026Z
DTSTART:20190602T113000Z
LOCATION:
SEQUENCE:0
SUMMARY:2019 PSI Annual Conference
UID:RFCALITEM639121404264057452
X-ALT-DESC;FMTTYPE=text/html:<p dir="ltr"> The theme for the PSI Conference
  2019 was<strong>&ldquo\;Data Driven Decision Making in Medical Research&r
 dquo\;.</strong>&nbsp\; The 2019 PSI Conference took place at the Queen El
 izabeth II Centre (QEII)\, London\, from&nbsp\;<strong>2nd&nbsp\;to 5th Ju
 ne 2019.</strong></p>\n<p dir="ltr">The conference consisted of a variety 
 of plenary and parallel sessions\, as well as breakout discussion sessions
 \, workshops\, a poster session and the Annual General Meeting. The confer
 ence ran over three full days from Monday to Wednesday\, with an optional 
 half day training course on the&nbsp\; Sunday afternoon.&nbsp\;</p>\n<p di
 r="ltr">Sessions included early phase innovative trial design\, industry b
 est practice - 10 years on\, statistical issues in safety drug labelling\,
  model based dose finding designs\, an update from Transcelerate and much 
 more\, with speakers from industry\, academia and regulatory agencies.<br 
 />\n<br />\nWe welcomed abstracts on any subject but were interested in th
 e following topics\; decision making\, bayesian topics within early or lat
 e phase\, causal inference\, future trends\, pre-clinical statistics\, pat
 ient reported outcomes\, and patient-centric data. </p>\n<p dir="ltr"><str
 ong>Kate Taylor</strong></p>\n<p dir="ltr"><em>PSI Conference Chair<br />\
 n</em></p>
END:VEVENT
END:VCALENDAR